ArticleCureus2026
Infectious Complications in Burn Patients: A 10-Year Multicenter Study in the Petróleos Mexicanos (PEMEX) Hospital Network.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Infections in Burn Patients: Pathophysiology, Prevention, and Contemporary Therapeutic Strategies in the Era of Antimicrobial Resistance.Infectious diseases and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfectious complications are a leading cause of morbidity and mortality in burn patients, particularly in tertiary care centers treating complex cases. The loss of the skin barrier, systemic inflammatory response, and secondary immunosuppression increase susceptibility to colonization, sepsis, and multidrug-resistant infections. Understanding the epidemiology and timing of these complications is critical to optimize prevention and treatment strategies. However, multicenter data describing long-term infection patterns and antimicrobial resistance in burn patients from Latin American healthcare networks remain limited. Additionally, evaluating a decade-long cohort allows for a more comprehensive characterization of epidemiological trends and resistance profiles over time.
objectiveThis study aims to determine the prevalence of infectious complications, microbiological profile, and associated risk factors in burn patients treated in the hospital network of Petróleos Mexicanos (PEMEX).
methodsWe conducted a multicenter, retrospective, observational study based on medical record review of burn patients hospitalized in six Petróleos Mexicanos (PEMEX) health centers across Mexico between 2014 and 2024. Demographic, clinical, and microbiological data were collected. Univariate analysis with chi-squared and Mann-Whitney U tests was performed, followed by logistic regression to identify independent risk factors associated with infection. A significance level of 5% was used.
resultsWe analyzed 273 hospitalized burn patients; 71.27% were men, and the mean age was 43.6 ± 18.8 years. The trunk was the most commonly affected area (52.36%), and 21.82% had burns >20% total body surface area (TBSA). The infection rate was 13.45%, with
conclusionsExtensive burns, ICU admission, lower extremity involvement, and older age are significant risk factors for infectious complications. The high prevalence of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.